LIXTE Biotechnology Holdings (ticker: LIXT and LIXTW), a Nasdaq-listed company, announced on September 10 that it has made an initial purchase of 10.5 bitcoins and 300 ethereum worth approximately $2.60 million as part of its capital diversification strategy. According to the announcement, cryptocurrencies currently account for 43.6% of LIXTE's capital holdings, and the company's board of directors has approved an increase in the allocation of cryptocurrencies to 50%. Geordan Pursglove, chairper...